Delivery Order SPE2DB24D1205-SPE2DB25FCXJC
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 17, 2025, for the supply of Zepbound 10 mg/0.5 mL pens valued at $7,637.15 with a completion date of June 18, 2025. This non-competitive delivery order utilizes firm fixed price pricing and represents a continuation of AmerisourceBergen's substantial pharmaceutical supply relationship with the federal government. The contract is a child order under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pens valued at $30,993.63, with a firm fixed price structure and no set-aside designation. The award was executed on June 5, 2025, with an ultimate completion date of June 6, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location. This delivery order represents a continuation of the company's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $1,664.58 firm fixed price delivery order for Zepbound 5 mg/0.5 ml pens on May 8, 2025, with completion scheduled for May 9, 2025. This competitively awarded, non-set-aside contract represents a single-line item pharmaceutical delivery to support federal medical supply needs. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order valued at $3,812.90 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pens on August 7, 2025. This firm fixed price delivery order, which was competitively awarded with no set-aside designation, is scheduled for completion by August 8, 2025, with the place of performance in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's broader contract vehicle with the Defense Logistics...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $41,202.03 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pens on August 21, 2025, with an ultimate completion date of August 22, 2025. This non-competitive, firm fixed-price delivery order is being fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The award represents a continuation of the company's role as a critical pharmaceutical supplier to federal medical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $18,845.38 for Zepbound 2.5 mg/0.5 mL pens on June 2, 2025, with completion scheduled for June 3, 2025. This firm fixed-price contract, executed without set-aside designation, represents a competitive award for pharmaceutical supply to support federal medical procurement needs. The delivery order was placed against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $36,636.21 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 ml pen injectors on September 4, 2025, with an ultimate completion date of September 5, 2025. This competitive award, which carries no set-aside designation, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is structured as a firm fixed-price contract and represents a single transaction under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $14,108.65 on September 9, 2025, for the supply of Zepbound 12.5 mg/0.5 mL pens. This firm fixed-price delivery order, which is not set-aside and competitively awarded, is scheduled for completion by September 10, 2025, with performance taking place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a continuation of the company's role as a critical pharmaceutical supplier...
- The Defense Logistics Agency awarded a delivery order valued at $27,721.55 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pens on August 29, 2025. This competitively awarded, firm fixed-price contract carries an ultimate completion date of September 2, 2025, and involves performance at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a discrete fulfillment under AmerisourceBergen's larger pharmaceutical supply relationship with the federal...
- The Defense Logistics Agency awarded a $26,811.86 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pens on May 30, 2025, with an ultimate completion date of June 2, 2025. This non-set-aside contract represents a small-value transaction within AmerisourceBergen's broader pharmaceutical supply portfolio and will be performed at the company's corporate office in Conshohocken, Pennsylvania. The delivery order is issued under...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FCXJCDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $15,401.14 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 ml pens on June 3, 2025, with an ultimate completion date of June 4, 2025. This non-competitive, firm fixed-price delivery order was placed against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999.00 potential value through December 2026. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government, particularly for military and veteran healthcare systems. The company maintains a comprehensive portfolio of pharmaceutical deliveries through the DLA Medical Supply Chain, including specialty medications, brand-name and generic drugs, vaccines, and medical devices. The Zepbound supply fulfills ongoing pharmaceutical needs within the Defense Health Agency and related federal healthcare programs. AmerisourceBergen's position as a pharmaceutical prime vendor underscores its capability to meet federal procurement requirements and support global military healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.4k | 6/3/25 |